Try our Investor Tool
Login
Sign Up
Login
Sign Up
Features
Pricing
Reg.News
Contact
Try our Investor Tool
Login
Sign Up
Search
Providers
Companies
⨯
LIVE
Event in Progress:
Join Here
×
Search
Providers
Companies
⨯
Features
Pricing
Event Hub
Reg.News
Short Interest
Contact
All the news articles and press releases in one place.
UK Reg. News
German Reg. News
Key Announcements
Results / Trading Updates
Get free RNS email alerts for@Model.CurrentFilterValue
Currently filtered for Dechra Pharmaceuticals PLC
Clear Filter
Search
Sector
Automobile Industry
Banks
Basic Materials
Building & Construction
Chemicals
Consumer Discretionary Goods
Consumer Discretionary Services
Consumer Staple Goods
Consumer Staple Services
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Finance
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Trusts, ETFs & Funds
Utilities
Market Cap
Below £20m
£20m - £100m
£100m - £300m
£300m - £1bn
£1bn - £10bn
Over £10bn
Filters »
All
UK100
UK250
UK SmallCap
UK Other
Show:
10
25
50
100
«
1
2
3
4
»
Date / Time
Source
Company
Sector
Market Cap
Announcement
05Dec16 11:06
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
30Nov16 15:04
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
30Nov16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
29Nov16 18:10
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Exercise of LTIP options
14Nov16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Additional Listing
09Nov16 14:54
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Appointment of Non-Executive Director
08Nov16 16:46
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Holding(s) in Company
31Oct16 14:16
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
21Oct16 14:51
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Result of AGM
21Oct16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Pre Annual General Meeting Statement
14Oct16 09:01
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Dechra complete acquisition in Australia
30Sep16 18:18
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
29Sep16 16:19
RNS
Schroders PLC
Various
Various
Holding(s) in Company
29Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Additional Listing
21Sep16 08:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
2016 Annual Financial Report
19Sep16 15:10
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
16Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Australian acquisition-Apex Laboratories for A$55m
15Sep16 15:29
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
09Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Approval for first US generic entrant antibiotic
06Sep16 10:58
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Availability of 2016 Annual Report and Accounts
05Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
2016 Preliminary Results Announcement
17Aug16 07:30
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Directorate Change
04Aug16 13:33
RNS
Schroders PLC
Various
Various
Holding(s) in Company
01Aug16 15:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
01Aug16 10:29
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Further re Directorate Change
12Jul16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Trading Update & Notice of Annual Results
30Jun16 09:52
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
06Jun16 15:12
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding - Replacement
06Jun16 13:34
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
16May16 15:37
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Holding(s) in Company
29Apr16 10:55
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
22Apr16 09:53
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Completion of Acquisition of Putney
15Apr16 14:59
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Update on Proposed Acquisition of Putney, Inc.
08Apr16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Directorate Change
31Mar16 13:17
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
21Mar16 14:16
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
18Mar16 15:14
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
17Mar16 13:11
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
15Mar16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Acquisition and Placing
29Feb16 09:36
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
22Feb16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Half-Yearly Financial Report 2016
08Feb16 15:44
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Additional Listing
01Feb16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
14Jan16 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Trading Update & Notice of Half-year results
31Dec15 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
30Nov15 09:13
RNS
Schroders PLC
Various
Various
Holding(s) in Company
30Nov15 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
16Nov15 09:11
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Additional Listing
11Nov15 08:33
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director Declaration
30Oct15 14:33
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
30Oct15 13:48
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Company Secretary Change
29Oct15 08:46
RNS
Legal & General Group Plc
Various
Various
Holding(s) in Company
23Oct15 16:36
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Result of AGM
23Oct15 07:00
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Trading Update
21Oct15 10:23
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Acquisition of Genera d.d.
01Oct15 16:23
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Director/PDMR Shareholding
01Oct15 09:36
RNS
Dechra Pharmaceuticals PLC
Health
£2,908m
Total Voting Rights
«
1
2
3
4
»
Date / Time
Source
Company
% Chg
05Dec16 11:06
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
30Nov16 15:04
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
30Nov16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
29Nov16 18:10
RNS
Dechra Pharmaceuticals PLC
-0.39%
Exercise of LTIP options
14Nov16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
09Nov16 14:54
RNS
Dechra Pharmaceuticals PLC
-0.39%
Appointment of Non-Executive Director
08Nov16 16:46
RNS
Dechra Pharmaceuticals PLC
-0.39%
Holding(s) in Company
31Oct16 14:16
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
21Oct16 14:51
RNS
Dechra Pharmaceuticals PLC
-0.39%
Result of AGM
21Oct16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Pre Annual General Meeting Statement
14Oct16 09:01
RNS
Dechra Pharmaceuticals PLC
-0.39%
Dechra complete acquisition in Australia
30Sep16 18:18
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
29Sep16 16:19
RNS
Schroders PLC
2.01%
Holding(s) in Company
29Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
21Sep16 08:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
2016 Annual Financial Report
19Sep16 15:10
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
16Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Australian acquisition-Apex Laboratories for A$55m
15Sep16 15:29
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
09Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Approval for first US generic entrant antibiotic
06Sep16 10:58
RNS
Dechra Pharmaceuticals PLC
-0.39%
Availability of 2016 Annual Report and Accounts
05Sep16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
2016 Preliminary Results Announcement
17Aug16 07:30
RNS
Dechra Pharmaceuticals PLC
-0.39%
Directorate Change
04Aug16 13:33
RNS
Schroders PLC
2.01%
Holding(s) in Company
01Aug16 15:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
01Aug16 10:29
RNS
Dechra Pharmaceuticals PLC
-0.39%
Further re Directorate Change
12Jul16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Trading Update & Notice of Annual Results
30Jun16 09:52
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
06Jun16 15:12
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding - Replacement
06Jun16 13:34
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
16May16 15:37
RNS
Dechra Pharmaceuticals PLC
-0.39%
Holding(s) in Company
29Apr16 10:55
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
22Apr16 09:53
RNS
Dechra Pharmaceuticals PLC
-0.39%
Completion of Acquisition of Putney
15Apr16 14:59
RNS
Dechra Pharmaceuticals PLC
-0.39%
Update on Proposed Acquisition of Putney, Inc.
08Apr16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Directorate Change
31Mar16 13:17
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
21Mar16 14:16
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
18Mar16 15:14
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
17Mar16 13:11
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
15Mar16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Acquisition and Placing
29Feb16 09:36
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
22Feb16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Half-Yearly Financial Report 2016
08Feb16 15:44
RNS
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
01Feb16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
14Jan16 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Trading Update & Notice of Half-year results
31Dec15 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
30Nov15 09:13
RNS
Schroders PLC
2.01%
Holding(s) in Company
30Nov15 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
16Nov15 09:11
RNS
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
11Nov15 08:33
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director Declaration
30Oct15 14:33
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
30Oct15 13:48
RNS
Dechra Pharmaceuticals PLC
-0.39%
Company Secretary Change
29Oct15 08:46
RNS
Legal & General Group Plc
1.72%
Holding(s) in Company
23Oct15 16:36
RNS
Dechra Pharmaceuticals PLC
-0.39%
Result of AGM
23Oct15 07:00
RNS
Dechra Pharmaceuticals PLC
-0.39%
Trading Update
21Oct15 10:23
RNS
Dechra Pharmaceuticals PLC
-0.39%
Acquisition of Genera d.d.
01Oct15 16:23
RNS
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
01Oct15 09:36
RNS
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
«
1
2
3
4
»
Date / Time
Company
% Chg
05Dec16 11:06
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
30Nov16 15:04
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
30Nov16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
29Nov16 18:10
Dechra Pharmaceuticals PLC
-0.39%
Exercise of LTIP options
14Nov16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
09Nov16 14:54
Dechra Pharmaceuticals PLC
-0.39%
Appointment of Non-Executive Director
08Nov16 16:46
Dechra Pharmaceuticals PLC
-0.39%
Holding(s) in Company
31Oct16 14:16
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
21Oct16 14:51
Dechra Pharmaceuticals PLC
-0.39%
Result of AGM
21Oct16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Pre Annual General Meeting Statement
14Oct16 09:01
Dechra Pharmaceuticals PLC
-0.39%
Dechra complete acquisition in Australia
30Sep16 18:18
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
29Sep16 16:19
DPH LSE,SDR LSE
2.01%
Holding(s) in Company
29Sep16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
21Sep16 08:00
Dechra Pharmaceuticals PLC
-0.39%
2016 Annual Financial Report
19Sep16 15:10
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
16Sep16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Australian acquisition-Apex Laboratories for A$55m
15Sep16 15:29
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
09Sep16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Approval for first US generic entrant antibiotic
06Sep16 10:58
Dechra Pharmaceuticals PLC
-0.39%
Availability of 2016 Annual Report and Accounts
05Sep16 07:00
Dechra Pharmaceuticals PLC
-0.39%
2016 Preliminary Results Announcement
17Aug16 07:30
Dechra Pharmaceuticals PLC
-0.39%
Directorate Change
04Aug16 13:33
DPH LSE,SDR LSE
2.01%
Holding(s) in Company
01Aug16 15:00
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
01Aug16 10:29
Dechra Pharmaceuticals PLC
-0.39%
Further re Directorate Change
12Jul16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Trading Update & Notice of Annual Results
30Jun16 09:52
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
06Jun16 15:12
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding - Replacement
06Jun16 13:34
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
16May16 15:37
Dechra Pharmaceuticals PLC
-0.39%
Holding(s) in Company
29Apr16 10:55
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
22Apr16 09:53
Dechra Pharmaceuticals PLC
-0.39%
Completion of Acquisition of Putney
15Apr16 14:59
Dechra Pharmaceuticals PLC
-0.39%
Update on Proposed Acquisition of Putney, Inc.
08Apr16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Directorate Change
31Mar16 13:17
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
21Mar16 14:16
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
18Mar16 15:14
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
17Mar16 13:11
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
15Mar16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Acquisition and Placing
29Feb16 09:36
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
22Feb16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Half-Yearly Financial Report 2016
08Feb16 15:44
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
01Feb16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
14Jan16 07:00
Dechra Pharmaceuticals PLC
-0.39%
Trading Update & Notice of Half-year results
31Dec15 07:00
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
30Nov15 09:13
DPH LSE,SDR LSE
2.01%
Holding(s) in Company
30Nov15 07:00
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
16Nov15 09:11
Dechra Pharmaceuticals PLC
-0.39%
Additional Listing
11Nov15 08:33
Dechra Pharmaceuticals PLC
-0.39%
Director Declaration
30Oct15 14:33
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
30Oct15 13:48
Dechra Pharmaceuticals PLC
-0.39%
Company Secretary Change
29Oct15 08:46
DPH LSE,LGEN LSE
1.72%
Holding(s) in Company
23Oct15 16:36
Dechra Pharmaceuticals PLC
-0.39%
Result of AGM
23Oct15 07:00
Dechra Pharmaceuticals PLC
-0.39%
Trading Update
21Oct15 10:23
Dechra Pharmaceuticals PLC
-0.39%
Acquisition of Genera d.d.
01Oct15 16:23
Dechra Pharmaceuticals PLC
-0.39%
Director/PDMR Shareholding
01Oct15 09:36
Dechra Pharmaceuticals PLC
-0.39%
Total Voting Rights
«
1
2
3
4
»
Strapline
Strapline
Question 1
Answer 1
Question 2
Answer 2
Question 3
Answer 3
Question 4
Answer 4
Question 5
Answer 5
Question 6
Answer 6
Question 7
Answer 7
Question 8
Answer 8
Top
Home
Features
Pricing
Event Hub
Reg.News
Short Interest Tracker
Blogs
Academy
Insights
News
Research Tree
The Naked Fund Manager
Ideas & Picks
Ideas Hub
Stock Pick League
Explore Content
Regions
UK
Rest of EMEA
N America
APAC
LatAm
Exchanges
Aquis Apex
Australian Securities Exchange
Canadian Securities Exchange
Euronext Paris
London Stock Exchange (domestic)
SIX Swiss Exchange
Sectors
Automobile Industry
Banks
Building & Construction
Chemicals
Discretionary Personal Goods
Discretionary Retail
Energy
ETFs
Financial Services
Food & Drink
Food Production
Health
Household Goods & DIY
Industrial Equipment, Goods & Services
Insurance & Reinsurance
Investment Trusts
Leisure, Tourism & Travel
Media
Open-ended Funds
Other
Real Estate
Resources
Staple Retail
Technology
Telecoms
Utilities
AIC Sectors
Asia Pacific
Asia Pacific Equity Income
Asia Pacific Smaller Companies
Biotechnology & Healthcare
China / Greater China
Commodities & Natural Resources
Country Specialist
Debt - Direct Lending
Debt - Loans & Bonds
Debt - Structured Finance
Environmental
Europe
European Smaller Companies
Farmland & Forestry
Financials
Flexible Investment
Global
Global Emerging Markets
Global Equity Income
Global Smaller Companies
Growth Capital
Hedge Funds
India
Infrastructure
Infrastructure Securities
Insurance & Reinsurance Strategies
Japan
Japanese Smaller Companies
Latin America
Leasing
Liquidity Funds
North America
North American Smaller Companies
Private Equity
Property - Debt
Property - Europe
Property - Rest of World
Property - UK Commercial
Property - UK Logistics
Property - UK Residential
Property Securities
Renewable Energy Infrastructure
Technology & Media
UK All Companies
UK Equity & Bond Income
UK Equity Income
UK Smaller Companies
VCT AIM Quoted
VCT Generalist
VCT Generalist Pre Qualifying
VCT Specialist: Environmental
VCT Specialist: Environmental Pre Qualifying
VCT Specialist: Healthcare & Biotechnology
Trust Managers
3i Group
3i Investments
Aberforth Partners
abrdn
AEW UK Investment Management
Albion Capital
Allianz Global Investors
Alpha Real Capital
Amati Global Investors
Amedeo Air Four Plus
Apax Guernsey Managers
Aquila Capital Investment
Artemis Investment Management
Asset Value Investors
Athelney Trust
Atrato Partners Limited
Augmentum Capital
Axiom Alternative Investments
Baillie Gifford
Baker Steel Capital
Beringea
BlackRock Investment Management (UK)
Boussard & Gavaudan Asset Management
Brevan Howard Capital Management
Chelverton Asset Management
Columbia Threadneedle
CVC Credit Partners
Doric Partners
Ecofin
Fidelity
Foresight Group
Frostrow Capital
Fundsmith
Gravis Capital Management
Greencoat Capital
Gresham House
Hansa Capital Partners
Harwood Capital
ICM
InfraRed Capital Partners
Invesco Asset Management
J.P. Morgan Asset Management
Janus Henderson Investors
Jupiter Unit Trust Managers
KKV Investment Management
Liontrust Asset Management
Markel CATCo Investment Management
Maven Capital Partners
MD Barnard and Co
Mercia Asset Management
Montanaro Investment Managers
Neuberger Berman Europe
New City Investment Managers
Octopus Investments
Pantheon Ventures
Phoenix Asset Management
Polar Capital Holdings
Premier Miton
Puma Investments
Quaero Capital
Rampart Capital
Ravenscroft
Riverstone International
Schroder Investment Management
Schroder Real Estate Management
Seneca Investment Managers
Triple Point Investment Management
Tritax Management
Troy Asset Management
TwentyFour Asset Management
White Oak Capital Partners
Willis Towers Watson
YFM Private Equity
Small / Large Cap
UK100
UK250
UK Smallcap
UK Other Main Markets
Other
Private/EIS
EIS Single Company
EIS/SEIS Funds
IHT Products
SEIS Single Company
VCT Funds
Providers
Free/Commissioned
ACF Equity Research
Align Research
BRR Media
Calvine Partners
Capital Access Group
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Doceo
Edison
Equity Development
eResearch
Fidante Partners
Five Minute Pitch TV
goetzpartners securities Limited
Hardman & Co
Inbound Capital
Independent Investment Research
InterAxS Global
Kepler | Trust Intelligence
London Stock Exchange
Magnitogorsk Iron and steel works
Mello Events
Mining Network
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Radnor Capital Partners
Research Tree
SEAL Advisors Ltd
ShareSoc
The AIC
Trinity Delta
UK Investor Group
Vox Markets
Yellowstone Advisory
High Net Worth Offering
Fox-Davies Capital
ACF Equity Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Auctus Advisors
Baptista Research
BNP Paribas Exane - Sponsored Research
Canaccord Genuity
Cenkos Securities
Couloir Capital
Dowgate Capital
finnCap
First Berlin
First Sentinel
Hannam & Partners
Hybridan
Kemeny Capital
Liberum
Longspur Research
Louis Capital
Magnitogorsk Iron and steel works
Medley Global Advisors
Northland Capital Partners
QuotedData Professional
Shard Capital
ShareSoc
Shore Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
The Life Sciences Division
VSA Capital
WHIreland
Whitman Howard
Yellowstone Advisory
Zeus Capital
Institutional Offering
Fox-Davies Capital
ACF Equity Research
Align Research
Allenby Capital
AlphaValue
Alternative Resource Capital
Arctic Securities
Arden Partners
Atrium Research
Auctus Advisors
Baptista Research
BNP Paribas Exane
BNP Paribas Exane - Sponsored Research
BRR Media
Bryan, Garnier & Co
Calderwood Capital
Calvine Partners
Canaccord Genuity
Capital Access Group
Cenkos Securities
Checkpoint Partners
Clear Capital Markets
Couloir Capital
Doceo
Dowgate Capital
Edison
Equity Development
eResearch
Fidante Partners
finnCap
First Berlin
First Sentinel
Five Minute Pitch TV
goetzpartners securities Limited
Hannam & Partners
Hardman & Co
Hybridan
Hypothesis Research
Inbound Capital
Independent Investment Research
InterAxS Global
Kemeny Capital
Kepler | Absolute Hedge
Kepler | Trust Intelligence
Liberum
London Stock Exchange
Longspur Research
Magnitogorsk Iron and steel works
Mello Events
Mining Network
Northland Capital Partners
Numis
Panmure Gordon
Peel Hunt
piworld.co.uk
Proactive
Progressive Equity Research
Quantum Research Group
QuotedData
RaaS - Research as a Service
Radnor Capital Partners
Research Tree
Resolve Research
SEAL Advisors Ltd
Shard Capital
ShareSoc
Shore Capital
SI Capital
Singer Capital Markets
SP Angel
Stanford Capital Partners
Stifel
Stifel FirstEnergy
Stockdale Securities
Tamesis Partners
The AIC
The Life Sciences Division
Trinity Delta
UK Investor Group
Velocity Trade
Vox Markets
VSA Capital
WHIreland
Whitman Howard
Winterflood Securities
Yellowstone Advisory
Zeus Capital
Video/Audio Interviews
BRR Media
Capital Access Group
Couloir Capital
Doceo
Edison
Equity Development
Five Minute Pitch TV
Mining Network
piworld.co.uk
Proactive
QuotedData
RaaS - Research as a Service
Research Tree
UK Investor Group
Vox Markets
Yellowstone Advisory
Event Providers
Capital Access Group
Cenkos Securities
Couloir Capital
Edison
Equity Development
Hardman & Co
InterAxS Global
Kepler | Trust Intelligence
London Stock Exchange
Mello Events
piworld.co.uk
Proactive
QuotedData
Research Tree
ShareSoc
The AIC
UK Investor Group
VSA Capital
Yellowstone Advisory
Contact
Sign Up
Sign In
Share: